The Quantitative Analysis of Drugs, 3e (PB)
Author : D.C. Garratt
Publisher :
Page : pages
File Size : 20,68 MB
Release : 2005-02-01
Category :
ISBN : 9788123907543
Author : D.C. Garratt
Publisher :
Page : pages
File Size : 20,68 MB
Release : 2005-02-01
Category :
ISBN : 9788123907543
Author : Donald Clarence. Garratt
Publisher : Springer Science & Business Media
Page : 937 pages
File Size : 39,20 MB
Release : 2012-12-06
Category : Science
ISBN : 1461333806
General Monographs, Alphabetically Arranged and Consisting of Methods for Quantitative Determination of the Substance, its Salts, and Preparations of Which it is a Principal Con- Stituent.- Synthetic Organic Compounds, Methods for Determination of Substances not Included in the General Monographs.- Essential Oils.- Oils, Fats and Waxes.- Appendices.- I. Determination of Alcohol Content.- II. Complexometric Titrations.- III. Non-aqueous Titrations.- IV. The Oxygen-Flask Combustion Technique.- V. Determination of Water.- VI. Extraneous Matter in Food and Drugs.- VII. Microbiological Assays.- VII.
Author :
Publisher : ScholarlyEditions
Page : 4231 pages
File Size : 45,47 MB
Release : 2012-01-09
Category : Medical
ISBN : 1464963428
Issues in Pharmacology, Pharmacy, Drug Research, and Drug Innovation: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Pharmacology, Pharmacy, Drug Research, and Drug Innovation. The editors have built Issues in Pharmacology, Pharmacy, Drug Research, and Drug Innovation: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Pharmacology, Pharmacy, Drug Research, and Drug Innovation in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Pharmacology, Pharmacy, Drug Research, and Drug Innovation: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Author : Andrew Pengelly
Publisher : CABI
Page : 249 pages
File Size : 45,29 MB
Release : 2021-04-19
Category : Science
ISBN : 1789243076
A classic in the literature of herbal medicine, this book explains in simple terms the commonly occurring chemical constituents of medicinal plants, and how these react with the human body. The major classes of plant constituents, such as phenols, terpenes and polysaccharides, are described both in terms of their chemical structures and their pharmacological activities. The last 20 years has seen huge growth in research output in phytochemistry, and this edition has been thoroughly revised to incorporate up-to-date research. It contains a new chapter on resins and cannabinoids, and additional content on macrocarpals, essential oil chemotypes, mushroom polysaccharides, phytochemical synergy, and toxicology of phytochemicals.
Author : Trisha M. Greenhalgh
Publisher : John Wiley & Sons
Page : 179 pages
File Size : 32,31 MB
Release : 2023-09-15
Category :
ISBN : 1394177208
Author : Sean Ekins
Publisher : John Wiley & Sons
Page : 840 pages
File Size : 42,18 MB
Release : 2006-07-11
Category : Medical
ISBN : 0470037229
A unique, holistic approach covering all functions and phases of pharmaceutical research and development While there are a number of texts dedicated to individual aspects of pharmaceutical research and development, this unique contributed work takes a holistic and integrative approach to the use of computers in all phases of drug discovery, development, and marketing. It explains how applications are used at various stages, including bioinformatics, data mining, predicting human response to drugs, and high-throughput screening. By providing a comprehensive view, the book offers readers a unique framework and systems perspective from which they can devise strategies to thoroughly exploit the use of computers in their organizations during all phases of the discovery and development process. Chapters are organized into the following sections: * Computers in pharmaceutical research and development: a general overview * Understanding diseases: mining complex systems for knowledge * Scientific information handling and enhancing productivity * Computers in drug discovery * Computers in preclinical development * Computers in development decision making, economics, and market analysis * Computers in clinical development * Future applications and future development Each chapter is written by one or more leading experts in the field and carefully edited to ensure a consistent structure and approach throughout the book. Figures are used extensively to illustrate complex concepts and multifaceted processes. References are provided in each chapter to enable readers to continue investigating a particular topic in depth. Finally, tables of software resources are provided in many of the chapters. This is essential reading for IT professionals and scientists in the pharmaceutical industry as well as researchers involved in informatics and ADMET, drug discovery, and technology development. The book's cross-functional, all-phases approach provides a unique opportunity for a holistic analysis and assessment of computer applications in pharmaceutics.
Author : Jürgen Bajorath
Publisher : Springer Science & Business Media
Page : 530 pages
File Size : 16,74 MB
Release : 2008-02-04
Category : Medical
ISBN : 1592598021
In the literature, several terms are used synonymously to name the topic of this book: chem-, chemi-, or chemo-informatics. A widely recognized de- nition of this discipline is the one by Frank Brown from 1998 (1) who defined chemoinformatics as the combination of “all the information resources that a scientist needs to optimize the properties of a ligand to become a drug. ” In Brown’s definition, two aspects play a fundamentally important role: de- sion support by computational means and drug discovery, which distinguishes it from the term “chemical informatics” that was introduced at least ten years earlier and described as the application of information technology to ch- istry (not with a specific focus on drug discovery). In addition, there is of course “chemometrics,” which is generally understood as the application of statistical methods to chemical data and the derivation of relevant statistical models and descriptors (2). The pharmaceutical focus of many developments and efforts in this area—and the current popularity of gene-to-drug or si- lar paradigms—is further reflected by the recent introduction of such terms as “discovery informatics” (3), which takes into account that gaining kno- edge from chemical data alone is not sufficient to be ultimately successful in drug discovery. Such insights are well in accord with other views that the boundaries between bio- and chemoinformatics are fluid and that these d- ciplines should be closely combined or merged to significantly impact b- technology or pharmaceutical research (4).
Author : Simon Shorvon
Publisher : Elsevier Health Sciences
Page : 377 pages
File Size : 47,36 MB
Release : 2008-12-30
Category : Medical
ISBN : 1437711316
This title in the acclaimed Blue Books of Neurology series highlights advances in epileptology and new ways of managing seizure disorders. Contributors from around the world—most new to this volume—lend a global perspective and provide the latest thinking on the new and controversial issues surrounding epilepsy. You’ll find detailed discussions of difficulties in diagnosing and treating epilepsy, including the latest pharmacologic management strategies. This book covers the entire range of issues in epilepsy from basic science research to current clinical issues to medical and surgical therapeutics. Find all you need on critical issues in treating epilepsy and seizure disorders. Provides the expertise of new contributors and volume editors who are world-class authorities in the field for authoritative guidance. Features thoroughly updated content including new chapters—Seizure Prediction; Drug Resistance Genes; Cortical Myoclonus and Epilepsy; Sudden Unexplained Death in Epilepsy; Seizures in the Elderly; Rasmussen’s Encephalitis; Epilepsies Due to Monogenic Disorders of Metabolism; Epilepsy and Sleep; Long-term Effects of Seizures on Brain Structure and Function; Brain Stimulation in Epilepsy—for the most current information for use in the decision-making process. Includes coverage of the surgical management of epilepsy to help you determine when it’s best to recommend surgery and for which patients. Emphasizes pharmacologic management of seizure patients that reflects advances in biotechnology and imaging.
Author : John Michels
Publisher :
Page : 960 pages
File Size : 29,64 MB
Release : 1925
Category : Science
ISBN :
Vols. for 1911-13 contain the Proceedings of the Helminothological Society of Washington, ISSN 0018-0120, 1st-15th meeting.
Author :
Publisher :
Page : 330 pages
File Size : 15,4 MB
Release : 1966
Category : Technology
ISBN :